Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2007; 13(33): 4445-4451
Published online Sep 7, 2007. doi: 10.3748/wjg.v13.i33.4445
Published online Sep 7, 2007. doi: 10.3748/wjg.v13.i33.4445
Table 1 Characteristics of H pylori-seropositive and -seronegative subjects
H pylori-seropositive(n = 237) | H pylori-seronegative(n = 173) | P-value | |||
n (%) | n (%) | ||||
Gender | 0.645 | ||||
Male | 234 | 98.7 | 171 | 98.8 | |
Female | 3 | 1.3 | 2 | 1.2 | |
Age (yr) | < 0.001 | ||||
< 45 | 30 | 12.7 | 63 | 36.4 | |
45-49 | 62 | 26.2 | 53 | 30.6 | |
50-54 | 85 | 35.9 | 43 | 24.9 | |
≥ 55 | 60 | 25.3 | 14 | 8.1 | |
Smoking | 0.281 | ||||
Never | 59 | 24.9 | 32 | 18.5 | |
Former | 76 | 32.1 | 57 | 32.9 | |
Current | 102 | 43.0 | 84 | 48.6 | |
Drinking | 0.023 | ||||
Never or rarely | 35 | 14.8 | 43 | 24.9 | |
1-5 times/wk | 131 | 55.3 | 91 | 52.6 | |
6-7 times/wk | 71 | 30.0 | 39 | 22.5 |
Table 2 H pylori seropositivity according to cytokine genotypes
H pylori-seropositive(n = 237) | H pylori-seronegative(n = 173) | P-value | |||
n | (%) | n | (%) | ||
IL1B-511C/T | 0.243 | ||||
CC | 93 | 39.2 | 54 | 31.2 | |
CT | 109 | 46.0 | 89 | 51.4 | |
TT | 35 | 14.8 | 30 | 17.3 | |
IL1B-31C/T | 0.434 | ||||
CC | 33 | 13.9 | 29 | 16.8 | |
CT | 112 | 47.3 | 87 | 50.3 | |
TT | 92 | 38.8 | 57 | 32.9 | |
IL6-634C/G | 0.753 | ||||
CC | 138 | 58.2 | 104 | 60.1 | |
CG | 88 | 37.1 | 59 | 34.1 | |
GG | 11 | 4.6 | 10 | 5.8 | |
TNF-1031T/C | 0.0 | 0.170 | |||
TT | 152 | 64.1 | 115 | 66.5 | |
CT | 80 | 33.8 | 51 | 29.5 | |
CC | 5 | 2.1 | 7 | 4.0 | |
TNF-857C/T | 0.018 | ||||
CC | 170 | 71.7 | 115 | 66.5 | |
CT | 64 | 27.0 | 47 | 27.2 | |
TT | 3 | 1.3 | 11 | 6.4 | |
IL10-1082A/G | 0.852 | ||||
AA | 211 | 89.0 | 153 | 88.4 | |
AG/GG1 | 26 | 11.0 | 20 | 11.6 |
Table 3 Age, gender-adjusted ORs for H pylori seropositivity according to cytokine genotypes
n | Hp (+)%1 | Adjusted OR (95%CI) | P-value | |
IL1B-511C/T | ||||
CC | 147 | 63.3 | 1.00 | |
CT | 198 | 55.1 | 0.69 (0.43-1.10) | 0.121 |
TT | 65 | 53.8 | 0.70 (0.37-1.32) | 0.270 |
IL1B-31C/T | ||||
CC | 62 | 53.2 | 1.00 | |
CT | 199 | 56.3 | 1.11 (0.61-2.05) | 0.726 |
TT | 149 | 61.7 | 1.47 (0.78-2.78) | 0.234 |
IL6-634C/G | ||||
CC | 242 | 57.0 | 1.00 | |
CG | 147 | 59.9 | 1.06 (0.68-1.66) | 0.785 |
GG | 21 | 52.4 | 0.63 (0.24-1.62) | 0.335 |
TNF-1031T/C | ||||
TT | 267 | 56.9 | 1.00 | |
CT | 131 | 61.1 | 1.24 (0.78-1.95) | 0.361 |
CC | 12 | 41.7 | 0.48 (0.13-1.70) | 0.253 |
TNF-857C/T | ||||
CC | 285 | 59.6 | 1.00 | |
CT | 111 | 57.7 | 0.93 (0.58-1.49) | 0.760 |
TT | 14 | 21.4 | 0.15 (0.03-0.59) | 0.007 |
IL10-1082A/G | ||||
AA | 364 | 58.0 | 1.00 | |
AG/GG2 | 46 | 56.5 | 1.08 (0.56-2.09) | 0.811 |
Table 4 Age, gender-adjusted ORs for H pylori seropositivity according to cytokine genotypes and lifestyle factors
IL1B–511C/T | |||||||
n | Hp (+)%1 | C/C | C/T | P-value | T/T | P-value | |
All subjects | 410 | 57.8 | 1.00 | 0.69 (0.43-1.10) | 0.121 | 0.70 (0.37-1.32) | 0.270 |
Smoking | |||||||
Never | 91 | 64.8 | 1.00 | 0.30 (0.10-0.90) | 0.032 | 0.40 (0.10-1.62) | 0.200 |
Former | 133 | 57.1 | 1.00 | 0.90 (0.39-2.10) | 0.819 | 0.74 (0.26-2.15) | 0.583 |
Current | 186 | 54.8 | 1.00 | 0.83 (0.42-1.63) | 0.582 | 0.80 (0.30-2.16) | 0.658 |
Drinking | |||||||
Never or rarely | 78 | 44.9 | 1.00 | 0.58 (0.20-1.66) | 0.310 | 1.38 (0.31-6.23) | 0.676 |
1-5 times/wk | 222 | 59.0 | 1.00 | 0.81 (0.43-1.55) | 0.531 | 0.38 (0.16-0.95) | 0.039 |
6-7 times/wk | 110 | 64.5 | 1.00 | 0.66 (0.25-1.69) | 0.383 | 1.11 (0.33-3.77) | 0.862 |
IL1B–31C/T | |||||||
n | Hp (+)%1 | C/C | C/T | P-value | T/T | P-value | |
All subjects | 410 | 57.8 | 1.00 | 1.11 (0.61-2.05) | 0.726 | 1.47 (0.78-2.78) | 0.234 |
Smoking | |||||||
Never | 91 | 64.8 | 1.00 | 0.79 (0.22-2.29) | 0.723 | 2.25 (0.56-9.08) | 0.257 |
Former | 133 | 57.1 | 1.00 | 1.34 (0.50-3.62) | 0.560 | 1.55 (0.55-4.42) | 0.409 |
Current | 186 | 54.8 | 1.00 | 1.20 (0.44-3.24) | 0.722 | 1.22 (0.44-3.40) | 0.705 |
Drinking | |||||||
Never or rarely | 78 | 44.9 | 1.00 | 0.44 (0.11-1.82) | 0.258 | 0.68 (0.15-3.12) | 0.624 |
1-5 times/wk | 222 | 59.0 | 1.00 | 2.59 (1.04-6.47) | 0.042 | 3.17 (1.23-8.14) | 0.017 |
6-7 times/wk | 110 | 64.5 | 1.00 | 0.72 (0.23-2.29) | 0.579 | 0.81 (0.24-2.73) | 0.735 |
IL6–634C/G | |||||||
n | Hp (+)%1 | C/C | C/G | P-value | G/G | P-value | |
All subjects | 410 | 57.8 | 1.00 | 1.06 (0.68-1.66) | 0.785 | 0.63 (0.24-1.62) | 0.335 |
Smoking | |||||||
Never | 91 | 64.8 | 1.00 | 0.54 (0.22-1.38) | 0.200 | 2.79 (0.28-27.73) | 0.382 |
Former | 133 | 57.1 | 1.00 | 0.63 (0.28-1.41) | 0.259 | 0.00 (0.00) | 0.999 |
Current | 186 | 54.8 | 1.00 | 2.28 (1.13-4.58) | 0.021 | 0.84 (0.22-3.15) | 0.796 |
Drinking | |||||||
Never or rarely | 78 | 44.9 | 1.00 | 1.07 (0.41-2.82) | 0.886 | 0.00 (0.00) | 1.000 |
1-5 times/wk | 222 | 59.0 | 1.00 | 1.02 (0.55-1.91) | 0.940 | 0.40 (0.11-0.41) | 0.153 |
6-7 times/wk | 110 | 64.5 | 1.00 | 1.61 (0.63-4.12) | 0.325 | 1.60 (0.28-9.28) | 0.599 |
Table 5 Age, gender-adjusted ORs for H pylori seropositivity according to the combination of the two promoter genotypes of TNF and IL1B
n | Hp (+)%1 | Adjusted OR (95%CI) | P-value | |
TNF-1031/-857 | ||||
TT/CC2 | 169 | 58.6 | 1.07 (0.70-1.64) | 0.743 |
TC/CC2 | 104 | 63.5 | 1.38 (0.85-2.25) | 0.195 |
CC/CC2 | 12 | 41.7 | 0.44 (0.13-1.57) | 0.207 |
TT/CT2 | 84 | 59.5 | 1.06 (0.63-1.78) | 0.830 |
TC/CT2 | 27 | 51.9 | 0.89 (0.39-2.02) | 0.781 |
TT/TT2 | 14 | 21.4 | 0.15 (0.04-0.60) | 0.007 |
IL1B-511/-313 | ||||
CC/TT2 | 141 | 61.7 | 1.29 (0.83-2.01) | 0.259 |
CT/CT2 | 191 | 54.5 | 0.74 (0.48-1.13) | 0.159 |
TT/CC2 | 59 | 52.5 | 0.77 (0.43-1.39) | 0.384 |
-
Citation: Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Sata F, Sato H, Kishi R.
H pylori seropositivity and cytokine gene polymorphisms. World J Gastroenterol 2007; 13(33): 4445-4451 - URL: https://www.wjgnet.com/1007-9327/full/v13/i33/4445.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i33.4445